Clinical Trials

36 enrolled

Small Cell Lung Carcinoma

NCT05092412 2024-01-12

Low-dose Radiotherapy Combined With Durvalumab, Chemotherapy(EP) in the Treatment of ES-SCLC

30 enrolled

Lung Neoplasms, Small Cell Lung Carcinoma

NCT03077828 2023-06-02

Pembrolizumab and Combination Chemotherapy in Treating Patients With Relapsed or Refractory Hodgkin Lymphoma

43 enrolled 9 charts

Hodgkin Disease

NCT05774028 2023-03-17

Pegaspargase Combined With Gemcitabine, Etoposide, Liposomal Mitoxantrone Hydrochloride and Dexamethasone (P-GEMD) in the Treatment of Untreated Early Non-upper Respiratory Tract or Advanced Extranodal NK/T-cell Lymphoma

50 enrolled

Lymphoma, Extranodal NK-T-Cell

NCT02099175 2023-03-13

Multidisciplinary Approach for Poor Prognosis Sinonasal Tumors in Operable Patients

41 enrolled

Sinonasal Tumors

NCT02099188 2023-03-13

Multidisciplinary Approach for Poor Prognosis Sinonasal Tumors in Inoperable Patients

27 enrolled

Unresectable Sinonasal Tumors

NCT02562365 2022-07-27

ACTS

130 enrolled

Ovarian Neoplasms

NCT03736616 2022-07-22

Acalabrutinib Plus RICE for Relapsed/Refractory DLBCL

47 enrolled

Lymphoma, Large B-Cell, Diffuse

NCT03570983 2022-06-22

BEAM

Plasma cell

Multiple Myeloma

NCT05422183 2022-06-16

Envafolimab, Lenvatinib Combined With VP-16 in Platinum-resistant Recurrent Epithelial Ovarian Cancer

Carcinoma, Ovarian Epithelial

NCT05354700 2022-05-04

A Clinical Study to Evaluate the Efficacy and Safety of HLX07 Combination Therapy in Patients With Extensive Small Cell Lung Cancer

Small Cell Lung Carcinoma

NCT05245994 2022-02-18

An Open Label, Multicenter Phase 2 Study of Durvalumab (MEDI4736) + Olaparib as Maintenance Therapy in Chinese

Lung Neoplasms, Small Cell Lung Carcinoma

NCT03837873 2022-01-26

DLCL002 Protocol for Patients With High Risk Aggressive B-cell Lymphoma

118 enrolled

Lymphoma, Large B-Cell, Diffuse

NCT03629873 2022-01-03

Efficacy and Safety of Chi-BEAC Combining With Auto-HSCT to Treat Aggressive Lymphoma Subjects

69 enrolled

Lymphoma, Large B-Cell, Diffuse, Lymphoma, T-Cell, Peripheral, Lymphoma, Mantle-Cell

NCT05049473 2021-09-20

Treatment of Mature B-ALL and Burkitt Lymphoma (BL) in Adult Patients. BURKIMAB-14.

Burkitt Lymphoma

NCT05034133 2021-09-05

Durvalumab With Chemotherapy Followed by Sequential Radiotherapy for Limited Stage Small Cell Lung Cancer

Limited Stage Small Cell Lung Cancer

NCT04217798 2021-09-01

Efficacy and Safety of Niraparib Combined With Oral Etoposide in Platinum Resistant/Refractory Recurrent Ovarian Cancer

36 enrolled

Ovarian Neoplasms

NCT05006664 2021-09-01

Brentuximab Vedotin in Combination With CHEP in Patient With PTCL

33 enrolled

Lymphoma, T-Cell, Peripheral

NCT04452370 2021-07-21

Oral Etoposide Combined With Anlotinib in Advanced Triple Negative Breast Cancer

Breast

Triple Negative Breast Neoplasms

NCT04917250 2021-06-08

GPED for Patients With Relapsed/Refractory or Advanced NK/T-cell Lymphoma

15 enrolled

Lymphoma, Extranodal NK-T-Cell

NCT02185352 2021-05-07

A-Plus

120 enrolled

BreastCNS

Brain Neoplasms, Breast Neoplasms

NCT04740021 2021-02-05

Study of LP002 in Combination With Chemotherapy for Patients With Extensive Stage Small Cell Lung Cancer

46 enrolled

Small Cell Lung Carcinoma

NCT02337712 2021-01-27

Once-daily Simultaneous Modulated Accelerated Thoracic Radiotherapy in Limited Small-cell Lung Cancer

198 enrolled

Small Cell Lung Carcinoma

NCT04696939 2021-01-06

Combined Atezolizumab and Chemotherapy (Carboplatin Plus Etoposide) in Neoadjuvant Treating Limited-Stage Small Cell Lung Cancer Patients

Small Cell Lung Carcinoma

NCT04683198 2020-12-24

Camrelizumab Combined With Apatinib ,Carboplatin and Etoposide in Participants With ES-SCLC

69 enrolled

Small Cell Lung Carcinoma

NCT02445404 2020-10-22

Compare Efficacy of CHOP Versus Fractionated ICED in Transplant-eligible Patients With Previously Untreated PTCL

134 enrolled

Lymphoma, T-Cell, Peripheral

NCT02544425 2020-10-22

VIDL+ASCT

27 enrolled

Lymphoma, Extranodal NK-T-Cell

NCT04543890 2020-09-10

CTV

300 enrolled

Small Cell Lung Cancer Limited Stage

NCT03389087 2020-07-10

Study of Apatinib Plus Etoposide Capsule as the Therapy of Advanced Small Cell Lung Cancer

Small Cell Lung Carcinoma

NCT04405375 2020-05-28

GPED Regimen for Relapsed/Refractory or Advanced ENKTCL

29 enrolled

LymphoidMyeloid

Lymphohistiocytosis, Hemophagocytic, Lymphoma, Extranodal NK-T-Cell

NCT04383977 2020-05-12

Apatinib and Etoposide Capsule Versus Apatinib in Patients With Platinum Resistant Ovarian Cancer

54 enrolled

Ovarian Neoplasms

NCT04363255 2020-04-28

First-line Chemotherapy Followed by Toripalimab Combined With Anlotinib for Maintenance in ES-SCLC

Small Cell Lung Carcinoma

NCT02638428 2020-03-19

Genomics-Based Target Therapy for Children With Relapsed or Refractory Malignancy

90 enrolled

Other solid neoplasm

Relapsed Pediatric Solid Tumor

NCT02784054 2020-03-19

Reduced Dose Radiotherapy Following High Dose Chemotherapy in Intracranial Non-germinomatous Germ Cell Tumor

25 enrolled

Intracranial Non-germinomatous Germ Cell Tumor

NCT03585998 2020-03-02

Chemoradiation With Durvalumab Followed by Durvalumab Maintenance for Limited Disease Small Cell Lung Cancer

51 enrolled

Small Cell Lung Carcinoma

NCT03613597 2020-02-05

Etoposide Plus Lobaplatin Versus Etoposide Plus Cisplatin for Patients With Limited Small-cell Lung Cancer

118 enrolled

Small Cell Lung Carcinoma

NCT04189094 2019-12-06

Chemoradiotherapy With or Without Sintilimab in Limited-stage SCLC

140 enrolled

Lung Neoplasms

NCT03700359 2019-11-29

A Study of Lobaplatin/Etoposide With or Without Anlotinib Maintenance Therapy in Patients With ES-SCLC

Small Cell Lung Carcinoma

NCT04061772 2019-08-20

A Study of Bortezomib Combined With CHEP in Peripheral T Cell Lymphoma

54 enrolled

Lymphoma, T-Cell, Peripheral

NCT03963193 2019-05-24

Etoposide/Cisplatin Compared With Irinotecan/Cisplatin for Advanced Gastrointestinal Neuroendocrine Tumor G3 Type

EndocrineGastrointestinalNET

112 enrolled

Gastro-enteropancreatic neuroendocrine tumor

NCT03923179 2019-04-22

Phase II Clinical Study of Pyrotinib Combined With Etoposide to Treat HER2-positive Advanced Breast Cancer

32 enrolled

Breast

Breast Neoplasms

NCT03841136 2019-03-28

Anlotinib Combined With Etoposide and Platinum in the Treatment of Lung Cancer

70 enrolled

Small Cell Lung Carcinoma

NCT01818908 2019-02-15

Trial of DA-EPOCH Regimen for NHL With HLH

50 enrolled

LymphoidMyeloid

Lymphoma, Non-Hodgkin, Lymphohistiocytosis, Hemophagocytic

NCT03781869 2018-12-20

Study of Anlotinib as the Maintenance Therapy for Extensive-stage Small Cell Lung Cancer

116 enrolled

Small Cell Lung Carcinoma

NCT03617432 2018-09-04

Chidamide Combined With CHOPE Regimen for Peripheral T-cell Lymphoma Patients

114 enrolled

Neoplasms, Experimental

NCT01857453 2018-07-05

RSMA2010

97 enrolled

CNS

Medulloblastoma

NCT03315520 2018-05-22

BeEAC-1

Hodgkin Disease, Lymphoma, Lymphoma, Non-Hodgkin

NCT03383406 2017-12-26

IVAM

30 enrolled

Lymphoma, Large B-Cell, Diffuse

NCT03135977 2017-12-07

Apatinib and Etoposide as the Maintenance Therapy in Extensive-stage Small Cell Lung Cancer After First-line Chemotherapy

36 enrolled

Lung Neoplasms, Small Cell Lung Carcinoma

NCT03154918 2017-11-08

GLIDE Regimen Followed by ASCT for Aggressive NK/T Cell Lymphoma